Skip to content
cccskills
FreePublished on GitHub

enda-stress-dose-hc-labor

Recommends hydrocortisone stress dosing during the active phase of labor for pregnant patients with primary adrenal insufficiency, using a regimen similar to major surgical stress. Trigger phrases: "active phase of labor", "cervix dilation ≥4 cm", "contractions every 5 minutes", "PAI patient in labor".

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.2 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Administer Hydrocortisone Stress Dosing During Active Phase of Labor

STEP 1 — Gather Information

Confirm diagnosis of primary adrenal insufficiency (PAI) in pregnant patient; assess labor status: active phase defined as cervix dilation ≥4 cm and/or regular contractions every 5 minutes for the last hour; obtain intravenous access; review allergies and contraindications.

STEP 2 — Rule In / Rule Out

Rule in if pregnant PAI patient is in active phase of labor (cervix ≥4 cm and/or contractions q5min). Rule out if not in active labor, patient lacks confirmed PAI, or has known hypersensitivity to hydrocortisone.

STEP 3 — Classify or Stratify

Proceed to stress dosing regimen; no further stratification needed as all active labor PAI patients receive same stress dose.

STEP 4 — Decide

Administer hydrocortisone 100 mg IV bolus followed by continuous infusion of 200 mg/24 hours (or equivalent) until delivery; after delivery, taper rapidly to prepregnancy maintenance dose.

Clinical Guardrails / Mimics / Pitfalls

Do not use dexamethasone (not inactivated by placenta); avoid delaying stress dosing until after delivery; monitor for signs of fluid overload or infection; ensure patient has steroid emergency card; consider mineralocorticoid replacement if hypotension persists despite glucocorticoid stress dosing.

Concrete Clinical Example

A 32-year-old woman with known PAI at 39 weeks gestation presents with regular contractions every 4 minutes and cervix 5 cm dilated. She receives hydrocortisone 100 mg IV bolus, then infusion 200 mg/24 hrs. After vaginal delivery 2 hours later, infusion is stopped and she resumes her usual oral hydrocortisone 20 mg daily.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill